Clinical Trial Update: Efficacy of Docetaxel, Capecitabine, Cisplatin, and Bevacizumab in Patients With Unresectable Advanced Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial updating efficacy of a combination regimen (docetaxel, capecitabine, cisplatin, and bevacizumab) in unresectable advanced gastric cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• CISPLATIN (cisplatin)
• Capecitabine (capecitabine)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Asan Medical Center | Conditions: Advanced Gastric Cancer | Phase 2 | Status: COMPLETED